Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of somitogenesis (GO:0014807) | 9.78855596 |
2 | copper ion transport (GO:0006825) | 9.58593512 |
3 | transepithelial transport (GO:0070633) | 7.14477704 |
4 | left/right pattern formation (GO:0060972) | 6.95325855 |
5 | tyrosine metabolic process (GO:0006570) | 6.31408028 |
6 | response to copper ion (GO:0046688) | 5.98364315 |
7 | serotonin metabolic process (GO:0042428) | 5.93219580 |
8 | adenosine metabolic process (GO:0046085) | 5.88884251 |
9 | regulation of oxidative phosphorylation (GO:0002082) | 5.87264242 |
10 | sensory perception of taste (GO:0050909) | 5.77791945 |
11 | sodium ion homeostasis (GO:0055078) | 5.66297036 |
12 | sperm capacitation (GO:0048240) | 5.20134056 |
13 | regulation of metalloenzyme activity (GO:0048552) | 5.13344543 |
14 | sequestering of metal ion (GO:0051238) | 5.04621419 |
15 | primary amino compound metabolic process (GO:1901160) | 5.02765356 |
16 | cellular zinc ion homeostasis (GO:0006882) | 4.97834112 |
17 | tryptophan metabolic process (GO:0006568) | 4.84343018 |
18 | import into cell (GO:0098657) | 4.67739047 |
19 | norepinephrine metabolic process (GO:0042415) | 4.67398308 |
20 | excretion (GO:0007588) | 4.67352195 |
21 | positive regulation of embryonic development (GO:0040019) | 4.60244244 |
22 | zinc ion homeostasis (GO:0055069) | 4.59502876 |
23 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.59169387 |
24 | bicarbonate transport (GO:0015701) | 4.59064493 |
25 | drinking behavior (GO:0042756) | 4.55967672 |
26 | protein localization to endosome (GO:0036010) | 4.16512920 |
27 | multicellular organismal water homeostasis (GO:0050891) | 4.08928084 |
28 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.01574510 |
29 | membrane hyperpolarization (GO:0060081) | 3.99027374 |
30 | forebrain neuron development (GO:0021884) | 3.95687687 |
31 | ethanol oxidation (GO:0006069) | 3.91892756 |
32 | opioid receptor signaling pathway (GO:0038003) | 3.88860085 |
33 | regulation of cardioblast proliferation (GO:0003264) | 3.85960721 |
34 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.85960721 |
35 | ferric iron transport (GO:0015682) | 3.73601392 |
36 | trivalent inorganic cation transport (GO:0072512) | 3.73601392 |
37 | removal of superoxide radicals (GO:0019430) | 3.63624761 |
38 | cellular response to superoxide (GO:0071451) | 3.63624761 |
39 | cellular response to oxygen radical (GO:0071450) | 3.63624761 |
40 | establishment of mitotic spindle orientation (GO:0000132) | 3.63105518 |
41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57401182 |
42 | vasodilation (GO:0042311) | 3.54406810 |
43 | lysosome localization (GO:0032418) | 3.53461636 |
44 | negative regulation of protein oligomerization (GO:0032460) | 3.52784672 |
45 | indolalkylamine metabolic process (GO:0006586) | 3.49421574 |
46 | aldehyde catabolic process (GO:0046185) | 3.42383540 |
47 | intraciliary transport (GO:0042073) | 3.37250787 |
48 | bone remodeling (GO:0046849) | 3.33669187 |
49 | transferrin transport (GO:0033572) | 3.23954508 |
50 | sensory perception of chemical stimulus (GO:0007606) | 3.23143112 |
51 | cellular transition metal ion homeostasis (GO:0046916) | 3.19757851 |
52 | ganglion development (GO:0061548) | 3.19522908 |
53 | water homeostasis (GO:0030104) | 3.19225684 |
54 | hepatocyte apoptotic process (GO:0097284) | 3.17295038 |
55 | secretory granule organization (GO:0033363) | 3.17192548 |
56 | pancreas development (GO:0031016) | 3.17149406 |
57 | extracellular matrix assembly (GO:0085029) | 3.16483620 |
58 | indole-containing compound metabolic process (GO:0042430) | 3.15957663 |
59 | AMP metabolic process (GO:0046033) | 3.13163759 |
60 | L-phenylalanine catabolic process (GO:0006559) | 3.12017481 |
61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.12017481 |
62 | response to pheromone (GO:0019236) | 3.09566808 |
63 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.08055981 |
64 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.08055981 |
65 | T-helper cell differentiation (GO:0042093) | 3.05643117 |
66 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.05643117 |
67 | establishment of mitotic spindle localization (GO:0040001) | 3.04565041 |
68 | protein localization to cilium (GO:0061512) | 3.03261975 |
69 | establishment of spindle orientation (GO:0051294) | 3.02375796 |
70 | outer ear morphogenesis (GO:0042473) | 2.99770041 |
71 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.95793831 |
72 | regulation of intracellular pH (GO:0051453) | 2.93827499 |
73 | apical protein localization (GO:0045176) | 2.83673369 |
74 | monovalent inorganic cation homeostasis (GO:0055067) | 2.81865075 |
75 | phagosome maturation (GO:0090382) | 2.78030441 |
76 | glucosamine-containing compound catabolic process (GO:1901072) | 2.76151490 |
77 | regulation of cellular pH (GO:0030641) | 2.73682398 |
78 | regulation of female gonad development (GO:2000194) | 2.69239753 |
79 | response to superoxide (GO:0000303) | 2.69151366 |
80 | positive regulation of vasodilation (GO:0045909) | 2.68937693 |
81 | transition metal ion homeostasis (GO:0055076) | 2.68698546 |
82 | transition metal ion transport (GO:0000041) | 2.67276207 |
83 | glial cell proliferation (GO:0014009) | 2.59884403 |
84 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.59173443 |
85 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.59173443 |
86 | T cell differentiation involved in immune response (GO:0002292) | 2.59173443 |
87 | cell differentiation involved in metanephros development (GO:0072202) | 2.58577692 |
88 | lateral sprouting from an epithelium (GO:0060601) | 2.58008121 |
89 | chloride transmembrane transport (GO:1902476) | 2.57886686 |
90 | ethanol metabolic process (GO:0006067) | 2.56419981 |
91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56043393 |
92 | central nervous system neuron development (GO:0021954) | 2.55876741 |
93 | omega-hydroxylase P450 pathway (GO:0097267) | 2.55374222 |
94 | L-phenylalanine metabolic process (GO:0006558) | 2.54272838 |
95 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.54272838 |
96 | urinary tract smooth muscle contraction (GO:0014848) | 2.53549932 |
97 | cytidine catabolic process (GO:0006216) | 2.53059785 |
98 | cytidine deamination (GO:0009972) | 2.53059785 |
99 | cellular copper ion homeostasis (GO:0006878) | 15.2094071 |
100 | copper ion homeostasis (GO:0055070) | 11.3916906 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 5.48202121 |
2 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 4.98578023 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.34638786 |
4 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.33219230 |
5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.59037907 |
6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.18184880 |
7 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.73750800 |
8 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.68694222 |
9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.57916655 |
10 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.51630142 |
11 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.16866088 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.15454823 |
13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12003533 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.11305013 |
15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08566637 |
16 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.97875568 |
17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91751968 |
18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87372497 |
19 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.84260914 |
20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83085669 |
21 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.79719743 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.76077987 |
23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.74280752 |
24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.74280752 |
25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.72244335 |
26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62974218 |
27 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.60451888 |
28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59124126 |
29 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.58418338 |
30 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55440307 |
31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.54379070 |
32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.54065702 |
33 | TP53_16413492_ChIP-PET_HCT116_Human | 1.53031071 |
34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41887501 |
35 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.38952139 |
36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37780200 |
37 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.36798222 |
38 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.36674866 |
39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.34865220 |
40 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.33941701 |
41 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.33124126 |
42 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.30686931 |
43 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.27833252 |
44 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.27655244 |
45 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.26103643 |
46 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25606389 |
47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.24842866 |
48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19413461 |
49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.15666279 |
50 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14293736 |
51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13497405 |
52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.12759480 |
53 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12157822 |
54 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11934135 |
55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11218675 |
56 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.09733168 |
57 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.09533147 |
58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09226989 |
59 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.08655559 |
60 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08654932 |
61 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.08346131 |
62 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07952808 |
63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07571824 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06910171 |
65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04508488 |
66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03564634 |
67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03330519 |
68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03065075 |
69 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03065075 |
70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02823213 |
71 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02822953 |
72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02458872 |
73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02123906 |
74 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00694315 |
75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96828549 |
76 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.95587051 |
77 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95570227 |
78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94275639 |
79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.94105760 |
80 | FUS_26573619_Chip-Seq_HEK293_Human | 0.92546777 |
81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92087186 |
82 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90962848 |
83 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90741719 |
84 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.88264657 |
85 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87879520 |
86 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86814718 |
87 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84891090 |
88 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.84502065 |
89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83644498 |
90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.82138658 |
91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81963882 |
92 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81020827 |
93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.80969618 |
94 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79939682 |
95 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79865044 |
96 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79727747 |
97 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.79101210 |
98 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.79097296 |
99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78789408 |
100 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.77947096 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004885_abnormal_endolymph | 6.48816407 |
2 | MP0002163_abnormal_gland_morphology | 5.70623722 |
3 | MP0002132_abnormal_respiratory_system | 5.20146110 |
4 | MP0005171_absent_coat_pigmentation | 4.57916069 |
5 | MP0003300_gastrointestinal_ulcer | 4.05730868 |
6 | MP0002277_abnormal_respiratory_mucosa | 3.96839357 |
7 | MP0001177_atelectasis | 3.40129308 |
8 | MP0005379_endocrine/exocrine_gland_phen | 3.31452039 |
9 | MP0005408_hypopigmentation | 3.29884880 |
10 | MP0000372_irregular_coat_pigmentation | 3.23983874 |
11 | MP0004742_abnormal_vestibular_system | 3.05988669 |
12 | MP0001485_abnormal_pinna_reflex | 2.93508066 |
13 | MP0009697_abnormal_copulation | 2.74297095 |
14 | MP0008438_abnormal_cutaneous_collagen | 2.60449415 |
15 | MP0001984_abnormal_olfaction | 2.41314726 |
16 | MP0000371_diluted_coat_color | 2.40953111 |
17 | MP0005220_abnormal_exocrine_pancreas | 2.36369678 |
18 | MP0003329_amyloid_beta_deposits | 2.34027520 |
19 | MP0008872_abnormal_physiological_respon | 2.29498176 |
20 | MP0005503_abnormal_tendon_morphology | 2.28509827 |
21 | MP0008789_abnormal_olfactory_epithelium | 2.06125033 |
22 | MP0005499_abnormal_olfactory_system | 2.00139301 |
23 | MP0005394_taste/olfaction_phenotype | 2.00139301 |
24 | MP0000462_abnormal_digestive_system | 1.93836254 |
25 | MP0005377_hearing/vestibular/ear_phenot | 1.90878400 |
26 | MP0003878_abnormal_ear_physiology | 1.90878400 |
27 | MP0005275_abnormal_skin_tensile | 1.86976927 |
28 | MP0002089_abnormal_postnatal_growth/wei | 1.83358865 |
29 | MP0000613_abnormal_salivary_gland | 1.83035606 |
30 | MP0002098_abnormal_vibrissa_morphology | 1.75852778 |
31 | MP0002168_other_aberrant_phenotype | 1.72606139 |
32 | MP0001756_abnormal_urination | 1.60796259 |
33 | MP0002133_abnormal_respiratory_system | 1.60266796 |
34 | MP0005388_respiratory_system_phenotype | 1.60266796 |
35 | MP0001963_abnormal_hearing_physiology | 1.47426655 |
36 | MP0005395_other_phenotype | 1.44911536 |
37 | MP0004133_heterotaxia | 1.43591831 |
38 | MP0006292_abnormal_olfactory_placode | 1.40081541 |
39 | MP0002233_abnormal_nose_morphology | 1.37822329 |
40 | MP0010234_abnormal_vibrissa_follicle | 1.35138080 |
41 | MP0002295_abnormal_pulmonary_circulatio | 1.34999852 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.34541414 |
43 | MP0003279_aneurysm | 1.19623309 |
44 | MP0005636_abnormal_mineral_homeostasis | 1.14285735 |
45 | MP0000604_amyloidosis | 1.13836590 |
46 | MP0000678_abnormal_parathyroid_gland | 1.08103502 |
47 | MP0005248_abnormal_Harderian_gland | 1.02777415 |
48 | MP0002075_abnormal_coat/hair_pigmentati | 1.01669421 |
49 | MP0003718_maternal_effect | 1.01590240 |
50 | MP0004043_abnormal_pH_regulation | 0.98128197 |
51 | MP0001186_pigmentation_phenotype | 0.97228599 |
52 | MP0000733_abnormal_muscle_development | 0.96327314 |
53 | MP0002933_joint_inflammation | 0.87538851 |
54 | MP0003879_abnormal_hair_cell | 0.87373399 |
55 | MP0003787_abnormal_imprinting | 0.85914757 |
56 | MP0001663_abnormal_digestive_system | 0.83806953 |
57 | MP0000026_abnormal_inner_ear | 0.81634343 |
58 | MP0001765_abnormal_ion_homeostasis | 0.79257223 |
59 | MP0005646_abnormal_pituitary_gland | 0.79024152 |
60 | MP0000569_abnormal_digit_pigmentation | 0.78675938 |
61 | MP0001175_abnormal_lung_morphology | 0.78136114 |
62 | MP0009643_abnormal_urine_homeostasis | 0.77341597 |
63 | MP0000049_abnormal_middle_ear | 0.73554946 |
64 | MP0001270_distended_abdomen | 0.72464102 |
65 | MP0010386_abnormal_urinary_bladder | 0.71021484 |
66 | MP0001849_ear_inflammation | 0.70301701 |
67 | MP0002249_abnormal_larynx_morphology | 0.69250753 |
68 | MP0009250_abnormal_appendicular_skeleto | 0.67030191 |
69 | MP0002102_abnormal_ear_morphology | 0.61485856 |
70 | MP0003690_abnormal_glial_cell | 0.60911613 |
71 | MP0000681_abnormal_thyroid_gland | 0.60334524 |
72 | MP0001664_abnormal_digestion | 0.59147089 |
73 | MP0004134_abnormal_chest_morphology | 0.57547959 |
74 | MP0000003_abnormal_adipose_tissue | 0.54501196 |
75 | MP0002136_abnormal_kidney_physiology | 0.54233273 |
76 | MP0003195_calcinosis | 0.53138308 |
77 | MP0002139_abnormal_hepatobiliary_system | 0.52410235 |
78 | MP0000631_abnormal_neuroendocrine_gland | 0.51930589 |
79 | MP0002932_abnormal_joint_morphology | 0.51644102 |
80 | MP0002938_white_spotting | 0.51538711 |
81 | MP0005174_abnormal_tail_pigmentation | 0.50630250 |
82 | MP0005381_digestive/alimentary_phenotyp | 0.49948852 |
83 | MP0003632_abnormal_nervous_system | 0.49463469 |
84 | MP0008875_abnormal_xenobiotic_pharmacok | 0.49363869 |
85 | MP0001486_abnormal_startle_reflex | 0.49161133 |
86 | MP0008569_lethality_at_weaning | 0.44921062 |
87 | MP0002229_neurodegeneration | 0.44680318 |
88 | MP0009745_abnormal_behavioral_response | 0.44204806 |
89 | MP0003283_abnormal_digestive_organ | 0.43936006 |
90 | MP0000534_abnormal_ureter_morphology | 0.41819559 |
91 | MP0002177_abnormal_outer_ear | 0.41568015 |
92 | MP0004272_abnormal_basement_membrane | 0.40936425 |
93 | MP0005167_abnormal_blood-brain_barrier | 0.39503304 |
94 | MP0002060_abnormal_skin_morphology | 0.39234359 |
95 | MP0005410_abnormal_fertilization | 0.38641080 |
96 | MP0003186_abnormal_redox_activity | 0.38053526 |
97 | MP0005508_abnormal_skeleton_morphology | 0.37688700 |
98 | MP0004782_abnormal_surfactant_physiolog | 0.37196195 |
99 | MP0003938_abnormal_ear_development | 0.34840704 |
100 | MP0010030_abnormal_orbit_morphology | 0.34466653 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypokalemic alkalosis (HP:0001949) | 9.85006799 |
2 | Hyperactive renin-angiotensin system (HP:0000841) | 8.34959985 |
3 | Abnormality of chloride homeostasis (HP:0011422) | 8.30975625 |
4 | Morphological abnormality of the inner ear (HP:0011390) | 8.16376381 |
5 | Renal salt wasting (HP:0000127) | 8.07847270 |
6 | Hyperaldosteronism (HP:0000859) | 7.94526257 |
7 | Hyperkalemia (HP:0002153) | 6.73068145 |
8 | Decreased circulating renin level (HP:0003351) | 6.60602627 |
9 | Chronic bronchitis (HP:0004469) | 6.57797909 |
10 | Hyponatremia (HP:0002902) | 6.12581967 |
11 | Ileus (HP:0002595) | 5.84462839 |
12 | Abnormality of the right ventricle (HP:0001707) | 5.81860897 |
13 | Alkalosis (HP:0001948) | 5.44326458 |
14 | Metabolic alkalosis (HP:0200114) | 5.22212103 |
15 | Abnormality of sodium homeostasis (HP:0010931) | 5.09863345 |
16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.84084516 |
17 | Male infertility (HP:0003251) | 4.83200812 |
18 | Rectal prolapse (HP:0002035) | 4.55850953 |
19 | Osteomalacia (HP:0002749) | 4.45520468 |
20 | Hypokalemia (HP:0002900) | 4.40659686 |
21 | Abnormality of potassium homeostasis (HP:0011042) | 4.08262698 |
22 | Adrenal overactivity (HP:0002717) | 4.01983337 |
23 | Hypothermia (HP:0002045) | 3.98118192 |
24 | Abnormality of renin-angiotensin system (HP:0000847) | 3.88286254 |
25 | Spinal muscular atrophy (HP:0007269) | 3.43111127 |
26 | Hypercalciuria (HP:0002150) | 3.15900752 |
27 | Broad ribs (HP:0000885) | 3.03817901 |
28 | Azoospermia (HP:0000027) | 2.95699115 |
29 | Tubulointerstitial nephritis (HP:0001970) | 2.91954631 |
30 | Spontaneous hematomas (HP:0007420) | 2.90133312 |
31 | Arterial tortuosity (HP:0005116) | 2.89206919 |
32 | Hypotension (HP:0002615) | 2.78632483 |
33 | Lip pit (HP:0100267) | 2.77677497 |
34 | Vascular calcification (HP:0004934) | 2.71822326 |
35 | Renal cortical cysts (HP:0000803) | 2.67489422 |
36 | Renal tubular dysfunction (HP:0000124) | 2.65935653 |
37 | Bronchitis (HP:0012387) | 2.64047005 |
38 | Exocrine pancreatic insufficiency (HP:0001738) | 2.60622069 |
39 | Polyuria (HP:0000103) | 2.56201008 |
40 | Bronchiectasis (HP:0002110) | 2.55091186 |
41 | Abnormality of the renal cortex (HP:0011035) | 2.53825016 |
42 | Vascular tortuosity (HP:0004948) | 2.51970785 |
43 | Tubulointerstitial abnormality (HP:0001969) | 2.46451661 |
44 | Cardiovascular calcification (HP:0011915) | 2.43848430 |
45 | Abnormality of Sharpey fibers (HP:0100685) | 2.34875083 |
46 | Abnormal urine output (HP:0012590) | 2.31953804 |
47 | Abnormality of the renal medulla (HP:0100957) | 2.29427487 |
48 | Chondrocalcinosis (HP:0000934) | 2.25667035 |
49 | Hyperphosphaturia (HP:0003109) | 2.25527059 |
50 | Dehydration (HP:0001944) | 2.24086038 |
51 | Esophageal varix (HP:0002040) | 2.22211292 |
52 | Tinnitus (HP:0000360) | 2.20388101 |
53 | Abnormality of renal excretion (HP:0011036) | 2.17458934 |
54 | Renal tubular acidosis (HP:0001947) | 2.12421029 |
55 | Tubulointerstitial fibrosis (HP:0005576) | 2.11263054 |
56 | Nephropathy (HP:0000112) | 2.10412844 |
57 | Metabolic acidosis (HP:0001942) | 2.09206337 |
58 | Stenosis of the external auditory canal (HP:0000402) | 2.05268531 |
59 | Abnormal spermatogenesis (HP:0008669) | 2.03077598 |
60 | Hip dysplasia (HP:0001385) | 2.01514627 |
61 | Abnormality of cochlea (HP:0000375) | 11.4402005 |
62 | Abnormal urine phosphate concentration (HP:0012599) | 1.99414019 |
63 | Hyperparathyroidism (HP:0000843) | 1.89231319 |
64 | Ureteral obstruction (HP:0006000) | 1.80179087 |
65 | Vertigo (HP:0002321) | 1.80099211 |
66 | Hepatitis (HP:0012115) | 1.79223982 |
67 | Nephrogenic diabetes insipidus (HP:0009806) | 1.79204078 |
68 | Nasolacrimal duct obstruction (HP:0000579) | 1.77336757 |
69 | Bladder diverticulum (HP:0000015) | 1.73919975 |
70 | Male pseudohermaphroditism (HP:0000037) | 1.73738337 |
71 | Goiter (HP:0000853) | 1.72270880 |
72 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.70971369 |
73 | Gastrointestinal dysmotility (HP:0002579) | 1.62218992 |
74 | Exostoses (HP:0100777) | 1.58455359 |
75 | Abnormality of urine glucose concentration (HP:0011016) | 1.56529508 |
76 | Glycosuria (HP:0003076) | 1.56529508 |
77 | Asymmetry of the thorax (HP:0001555) | 1.53341151 |
78 | Tarsal synostosis (HP:0008368) | 1.51103270 |
79 | Redundant skin (HP:0001582) | 1.50502813 |
80 | Orthostatic hypotension (HP:0001278) | 1.49008026 |
81 | Tracheal stenosis (HP:0002777) | 1.48553979 |
82 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.46006983 |
83 | Aplasia of the phalanges of the hand (HP:0009802) | 1.46006983 |
84 | Aplasia involving bones of the extremities (HP:0009825) | 1.46006983 |
85 | Abnormality of the nasolacrimal system (HP:0000614) | 1.43256034 |
86 | Short humerus (HP:0005792) | 1.41293453 |
87 | Enlarged kidneys (HP:0000105) | 1.41232896 |
88 | Synostosis involving bones of the feet (HP:0009140) | 1.37459411 |
89 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.37459411 |
90 | Limited elbow extension (HP:0001377) | 1.37458769 |
91 | Abnormality of the lacrimal duct (HP:0011481) | 1.35745602 |
92 | Pulmonary fibrosis (HP:0002206) | 1.35544341 |
93 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.34031824 |
94 | Woolly hair (HP:0002224) | 1.32204572 |
95 | Drooling (HP:0002307) | 1.30533448 |
96 | Excessive salivation (HP:0003781) | 1.30533448 |
97 | Delayed CNS myelination (HP:0002188) | 1.29952473 |
98 | Abnormality of the diencephalon (HP:0010662) | 1.29203559 |
99 | Personality changes (HP:0000751) | 1.25579369 |
100 | Severe visual impairment (HP:0001141) | 1.23117277 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRKG2 | 3.62693193 |
2 | NEK1 | 2.59349491 |
3 | LMTK2 | 15.2866204 |
4 | FRK | 1.96512241 |
5 | MAP3K3 | 1.62866403 |
6 | STK39 | 1.38058444 |
7 | PINK1 | 1.27069916 |
8 | ZAK | 1.19995241 |
9 | TAOK1 | 1.15812758 |
10 | ERBB3 | 1.12905020 |
11 | ROCK1 | 1.11224126 |
12 | BMPR2 | 1.06251055 |
13 | MAPK15 | 1.02972704 |
14 | SIK2 | 0.94573123 |
15 | MAP3K2 | 0.91862797 |
16 | NTRK3 | 0.81718435 |
17 | OXSR1 | 0.80453970 |
18 | MAP2K3 | 0.76581221 |
19 | LATS1 | 0.75190336 |
20 | CSNK1G2 | 0.68815514 |
21 | TAOK2 | 0.68381743 |
22 | STK10 | 0.68192645 |
23 | SRPK1 | 0.67353604 |
24 | WNK4 | 0.67060524 |
25 | RPS6KB2 | 0.63529521 |
26 | PAK3 | 0.61176450 |
27 | MAP3K11 | 0.60861430 |
28 | ROCK2 | 0.58793512 |
29 | ADRBK1 | 0.58558577 |
30 | PTK2 | 0.53313175 |
31 | UHMK1 | 0.52148630 |
32 | MST4 | 0.51728970 |
33 | BCR | 0.51576187 |
34 | IRAK2 | 0.50215682 |
35 | HIPK2 | 0.49739657 |
36 | TXK | 0.48864814 |
37 | PRPF4B | 0.47019363 |
38 | CDC42BPA | 0.46290854 |
39 | PRKCE | 0.44898068 |
40 | SIK3 | 0.42735710 |
41 | NUAK1 | 0.41798072 |
42 | PRKAA1 | 0.41561098 |
43 | STK38L | 0.41123175 |
44 | TNIK | 0.37899208 |
45 | FER | 0.36875130 |
46 | CDK6 | 0.36468455 |
47 | LATS2 | 0.33601634 |
48 | RIPK4 | 0.33562015 |
49 | MARK2 | 0.32260944 |
50 | PNCK | 0.31753383 |
51 | DAPK2 | 0.31625966 |
52 | BRD4 | 0.31317056 |
53 | ERBB2 | 0.31290061 |
54 | FGFR2 | 0.31214425 |
55 | CSNK1A1L | 0.31023748 |
56 | GRK6 | 0.27955083 |
57 | PDK2 | 0.27945731 |
58 | ERN1 | 0.27480507 |
59 | NEK6 | 0.26780720 |
60 | CAMK2D | 0.26562358 |
61 | TTK | 0.24422175 |
62 | MARK1 | 0.22724072 |
63 | DMPK | 0.22600699 |
64 | PRKG1 | 0.21496498 |
65 | PLK3 | 0.20283368 |
66 | CASK | 0.19265001 |
67 | PLK4 | 0.19187016 |
68 | NEK2 | 0.18964196 |
69 | BLK | 0.18833194 |
70 | CSNK1G3 | 0.18308684 |
71 | SGK3 | 0.17590652 |
72 | CAMK2B | 0.15965058 |
73 | PRKD1 | 0.15918065 |
74 | MINK1 | 0.15642526 |
75 | PRKCH | 0.15604148 |
76 | TYRO3 | 0.14413907 |
77 | TRPM7 | 0.14025804 |
78 | MAP2K1 | 0.13894176 |
79 | TYK2 | 0.13815947 |
80 | MARK3 | 0.13671756 |
81 | PKN1 | 0.13294686 |
82 | EIF2AK3 | 0.12344274 |
83 | CAMK1 | 0.11422507 |
84 | PRKCG | 0.11103359 |
85 | FGFR3 | 0.11098956 |
86 | CSNK1G1 | 0.10611501 |
87 | EIF2AK2 | 0.10180520 |
88 | CAMK2A | 0.09245121 |
89 | SIK1 | 0.08945906 |
90 | PRKACA | 0.08940750 |
91 | PRKCQ | 0.08856606 |
92 | PRKCA | 0.08288845 |
93 | EPHA4 | 0.07222932 |
94 | SGK2 | 0.06822560 |
95 | ATM | 0.06365427 |
96 | PRKCD | 0.06260944 |
97 | PLK2 | 0.05554198 |
98 | PDGFRB | 0.05491886 |
99 | PRKCB | 0.04331816 |
100 | CHUK | 0.03612929 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.54310623 |
2 | Taste transduction_Homo sapiens_hsa04742 | 4.52035768 |
3 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 4.48606230 |
4 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 3.86982910 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 3.09229329 |
6 | Mineral absorption_Homo sapiens_hsa04978 | 2.81507611 |
7 | ABC transporters_Homo sapiens_hsa02010 | 2.64546180 |
8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.36587442 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.31883535 |
10 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.26288512 |
11 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.18683219 |
12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02827886 |
13 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.02431507 |
14 | Renin secretion_Homo sapiens_hsa04924 | 1.69187982 |
15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64425237 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.63443161 |
17 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.57238650 |
18 | Bile secretion_Homo sapiens_hsa04976 | 1.47548123 |
19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36451402 |
20 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.29321506 |
21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28529832 |
22 | Salivary secretion_Homo sapiens_hsa04970 | 1.25244022 |
23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.16267460 |
24 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09986890 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.08425673 |
26 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.04488057 |
27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04042570 |
28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.02303984 |
29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.01096129 |
30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98901251 |
31 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.96260065 |
32 | Morphine addiction_Homo sapiens_hsa05032 | 0.95508732 |
33 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95349436 |
34 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95174018 |
35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93288920 |
36 | Phototransduction_Homo sapiens_hsa04744 | 0.89801613 |
37 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.88122967 |
38 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86694789 |
39 | Peroxisome_Homo sapiens_hsa04146 | 0.85425790 |
40 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85374494 |
41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82647704 |
42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81586464 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78259154 |
44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78029301 |
45 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75791284 |
46 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.72514304 |
47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70972311 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.69428734 |
49 | Axon guidance_Homo sapiens_hsa04360 | 0.68912432 |
50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.67706378 |
51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62726486 |
52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62447477 |
53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62000043 |
54 | Insulin secretion_Homo sapiens_hsa04911 | 0.60449728 |
55 | Tight junction_Homo sapiens_hsa04530 | 0.57106726 |
56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.55850349 |
57 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55584421 |
58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54515371 |
59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54487737 |
60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54390621 |
61 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52801836 |
62 | Adherens junction_Homo sapiens_hsa04520 | 0.52449919 |
63 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51798594 |
64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51347000 |
65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51094340 |
66 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50558020 |
67 | Platelet activation_Homo sapiens_hsa04611 | 0.50550670 |
68 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.50350785 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49693504 |
70 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48882548 |
71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48783195 |
72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47896181 |
73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.46515739 |
74 | Phagosome_Homo sapiens_hsa04145 | 0.45275150 |
75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45236336 |
76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.43382203 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43189174 |
78 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42276100 |
79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.42103311 |
80 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41629719 |
81 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40548988 |
82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40462831 |
83 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38566023 |
84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38319792 |
85 | Long-term depression_Homo sapiens_hsa04730 | 0.37205539 |
86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.36658955 |
87 | Gap junction_Homo sapiens_hsa04540 | 0.35968718 |
88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33191793 |
89 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.31448838 |
90 | Focal adhesion_Homo sapiens_hsa04510 | 0.29126916 |
91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.29018590 |
92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27982113 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.27121590 |
94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26671884 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25303332 |
96 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25119196 |
97 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22811869 |
98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.22189135 |
99 | Nicotine addiction_Homo sapiens_hsa05033 | 0.21988709 |
100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21907604 |